73 completed, 16 unknown, 6 recruiting, 6 terminated. 110 Phase 1, 33 Phase 2.
Follow Exercise: new trials by email Literature Review of Exercise trials Research Report on Exercise
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial (-)-Epicatechin-rich cocoa supplementation combined with exercise training, Placebo combined with exercise training - Mobility Disability | Phase 1 / Phase 2 | Recruiting | University of Alabama at Birmingham | 36 | 2026-04-21 | 2026-05-08 |
| Gymnastics and Multicomponent Training Intervention in Community-dwelling Older Adults Multicomponent training intervention Multicomponent training intervention - Protocol includes mobility, resistance exercises for the lower and upper limbs and major muscle groups, and aerobic exercise - Older Adults (60 - 85 Years Old) | Phase 1 | Enrolling by invitation | Federal University of the Valleys of Jequitinhonha and Mucuri | 80 | 2026-02-20 | 2026-08-17 |
| A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus AZD6793, AZD6793 Placebo - Type 2 Diabetes Mellitus | Phase 1 | Suspended | AstraZeneca | 28 | 2026-01-14 | 2026-04-22 |
| Trial on Single/Multiple Ascending Doses for Safety, PK and PD for CBP-0276 in Healthy Subjects CBP-0276 Acetate, Placebo for CBP-0276 Acetate - Healthy Volunteers | Phase 1 | Completed | Clarent Biopharma, Inc. | 64 | 2025-09-04 | 2026-10-16 |
| Double Dose 4-AP on Functional Recovery After Spinal Cord Injury Dalfampridine, Placebo, STDP stimulation - SCI - Spinal Cord Injury | Phase 1 / Phase 2 | Recruiting | Shirley Ryan AbilityLab | 27 | 2025-02-01 | 2026-06-03 |
| Roflumilast and TMS Motor Plasticity Roflumilast, Placebo, Intermittent theta-burst stimulation transcranial magnetic stimulation - Other Conditions of Brain | Phase 1 | Active not recruiting | University of Calgary | 20 | 2024-11-06 | 2025-07-03 |
| Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients Oral 100 gram Empagliflozin tablet along with diet plan and exercise, Diet plan and exercise - Diabete Mellitus | Phase 1 | Completed | Ariba Shafiq | 360 | 2024-10-01 | 2026-01-26 |
| Pilot - Resistance Exercise for Inpatient Treatment in T2D Exercise - Diabetes Mellitus, Type 2, Prediabetes or Diabetes | Phase 1 | Terminated | Copenhagen University Hospital, Rigshospitalet | 4 | 2024-08-12 | 2026-01-21 |
| Comparative Exercise-Induced Hypoalgesia in Upper and Lower Limbs: A Randomized Controlled Trial in Healthy Individuals Aerobic exercise - Healthy Subjects | Phase 1 | Recruiting | Centro Universitario La Salle | 90 | 2024-04-23 | 2025-02-27 |
| Behavioral Exercise Training to Reduce Cardiovascular Disease Risk Exercise Training Intervention, Healthy Living Education - Prostate Cancer, Supportive Care | Phase 1 / Phase 2 | Recruiting | Virginia Commonwealth University | 60 | 2024-02-21 | 2026-03-02 |
| A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV Placebo, Active - Respiratory Syncytial Virus Infections | Phase 1 | Terminated | Pfizer | 10 | 2024-02-15 | 2025-12-30 |
| A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease BMS-984923, Placebo - Alzheimer's Disease | Phase 1 | Completed | Allyx Therapeutics | 51 | 2023-03-28 | 2025-11-06 |
| Effect of Respiratory Muscle Training on Lung Function on Quarry Workers in Minia Government Egypt aerobic exercises with electrical treadmill for 30 min and inspiratory muscle training for 10 minutes., - Lung Function Decreased | Phase 1 | Completed | Deraya University | 40 | 2023-01-02 | 2023-11-07 |
| Study of Single and Multiple Doses of PRS-220 Administered by Oral Inhalation in Healthy Subjects Placebo, PRS-220 - Healthy | Phase 1 | Completed | Pieris Australia Pty Ltd | 64 | 2022-10-31 | 2023-10-23 |
| Modulating Exercise Dosage to Improve Concussion Recovery High Dose Exercise - Concussion, Brain, Treatment | Phase 1 / Phase 2 | Recruiting | University of Colorado, Denver | 178 | 2022-08-05 | 2026-08-31 |
| OA Optimization Program Pilot Trial Alberta Healthy Living Program, Alberta Obesity Centre Program, Osteoarthritis advice - Osteo Arthritis Knee, Osteoarthritis, Knee | Phase 1 / Phase 2 | Unknown | University of Calgary | 70 | 2022-06-28 | 2024-05-22 |
| Phase I Study of GN-037 Cream for Psoriasis GN037, Placebo - Psoriasis | Phase 1 | Completed | TC Erciyes University | 24 | 2022-03-28 | 2023-06-13 |
| CC-42344 Safety Study in Healthy Participants CC-42344, Placebo - Influenza A | Phase 1 | Completed | Cocrystal Pharma, Inc. | 80 | 2022-02-11 | 2026-02-19 |
| Aerobic Exercise After Traumatic Brain Injury Aerobic Exercise (AER), Rehabilitation - Traumatic Brain Injury | Phase 1 / Phase 2 | Enrolling by invitation | Centre for Neuro Skills | 190 | 2022-01-18 | 2023-03-28 |
| A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB PDC-APB, Placebo - Contact Dermatitis | Phase 1 | Unknown | Hapten Sciences, Inc. | 32 | 2021-11-01 | 2021-08-27 |
Showing 20 of 110. Sign in to see all of them.
Motor Activity (41) · Diabetes Mellitus, Type 2 (9) · Obesity (7) · Diabetes Mellitus (6) · Cardiovascular Diseases (4) · Neoplasms (4) · Depression (3) · Metabolic Syndrome (3) · Multiple Sclerosis (3) · Osteoarthritis (3) · Overweight (3) · Asthma (2) · Brain Injuries, Traumatic (2) · Breast Neoplasms (2) · Cerebral Palsy (2)
Mayo Clinic (5) · Pfizer (4) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · University of Calgary (3) · Centre for Neuro Skills (2) · Copenhagen University Hospital, Rigshospitalet (2) · Emory University (2) · Hapten Sciences, Inc. (2) · National Institute on Aging (NIA) (2) · National Taiwan University Hospital (2) · The University of Texas Medical Branch, Galveston (2) · University of Isfahan (2) · University of Saskatchewan (2) · Allyx Therapeutics (1) · Anders Rasmussen Rinnov (1)
United States (52) · Canada (10) · Brazil (4) · Denmark (4) · Japan (4) · Australia (3) · Germany (3) · Taiwan (3) · Norway (2) · Spain (2) · United Kingdom (2) · Austria (1) · Belgium (1) · Egypt (1) · Ireland (1)
Grace S Griesbach, PhD (2) · Lori Roust, MD (2) · Adam Mecca, MD, PhD (1) · Alexander R Lucas, PhD (1) · Andrea L Dunn, PhD (1) · Annemarie L Lee, PhD (1) · Anthony Spirito, PhD (1) · Axel Linke, MD (1) · Barbara Giesser, MD (1) · Beth A. Lewis, PhD (1) · Bettina Breitowicz, MD (1) · Bibi Gram, M.Sc.,PT (1) · Bijan Najafi, PhD (1) · Brian Maki, PhD, PEng (1)
PMID 15096581, PMID 15681386, PMID 16756656, PMID 17159017, PMID 17167156, PMID 17540020, PMID 20122281, PMID 20167644, PMID 20214807, PMID 20634268, PMID 20925931, PMID 21045179, PMID 21233083, PMID 21325343, PMID 21820536, PMID 21961534, PMID 22127229, PMID 22515800, PMID 23154216, PMID 23185357, PMID 23186730, PMID 23220074, PMID 23229158, PMID 23690322, PMID 24074360, PMID 24450370, PMID 24506509, PMID 24635447, PMID 24731015, PMID 25224876, PMID 25262271, PMID 25540170, PMID 25613340, PMID 26252343, PMID 26348542, PMID 26395209, PMID 26541890, PMID 26980363, PMID 27097799, PMID 27310418, PMID 27439082, PMID 28735720, PMID 28820909, PMID 28939263, PMID 29029131, PMID 29642282, PMID 29750251, PMID 29896930, PMID 30201848, PMID 30253140
2023 (1), K01HL161419 (1), K23AT001879 (1), R01AG021539 (1), R01AG030070 (1), R01AG073177 (1), R01DK059358 (1), R01DK063226 (1), R01HD108133 (1), R01HL072947 (1), R21AG092916 (1), R21DA045101 (1), R21HL092340 (1), R34MH083092 (1), R44CA143716 (1)